Cargando…
Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis
While no curative treatment exists for multiple sclerosis (MS), several disease-modifying therapies (DMTs) have been developed to reduce relapse rates, slow disability progression, and modify the overall disease course. However, because of the chronic nature of the disease, long-term therapy adheren...
Autores principales: | Menzin, Joseph, Caon, Christina, Nichols, Christine, White, Leigh Ann, Friedman, Mark, Pill, Michael W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437533/ https://www.ncbi.nlm.nih.gov/pubmed/23383731 http://dx.doi.org/10.18553/jmcp.2013.19.s1.S24 |
Ejemplares similares
-
Perspectives for Managed Care Organizations on the Burden of Multiple Sclerosis and the Cost-Benefits of Disease-Modifying Therapies
por: Owens, Gary M., et al.
Publicado: (2013) -
Applications of Disease Benchmarks and Case Presentations
por: Pill, Michael W.
Publicado: (2005) -
Medication Adherence
por: Gold, Deborah T.
Publicado: (2006) -
Emerging Methods for Evaluating the Effectiveness of Intramuscular Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis
por: Foley, John F., et al.
Publicado: (2013) -
Influencing Patient Adherence to Treatment Guidelines
por: Butterworth, Susan W.
Publicado: (2008)